🇺🇸 FDA
Pipeline program

CD19 CAR-T cells infusion

PG-CART-19-001

Unknown mab active

Quick answer

CD19 CAR-T cells infusion for Non Hodgkin Lymphoma is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Non Hodgkin Lymphoma
Phase
Unknown
Modality
mab
Status
active

Clinical trials